Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels-Reference-Cited by-同舟云学术

Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels

Published:2007-10 Issue:10 Volume:9 Page:1058-1063
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Hessel Marleen H.M.¹,Bleeker Gabe B.¹,Bax Jeroen J.¹,Henneman Maureen M.¹,den Adel Brigit¹,Klok Margreet¹,Schalij M.J.¹,Atsma Douwe E.,van der Laarse Arnoud¹

Affiliation:

1. Department of Cardiology; Leiden University Medical Center; Leiden The Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.ejheart.2007.07.007/fullpdf

Reference33 articles.

1. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society;Strickberger;Circulation,2005

2. Cardiac resynchronization in chronic heart failure;Abraham;N Engl J Med,2002

3. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure;John Sutton;Circulation,2003